Dynavax Technologies Corporation
Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine
Published in Vaccine Weekly, August 13th, 2008
Dynavax Technologies Corporation (Nasdaq:DVAX) announced an agreement with Novartis Vaccines and Diagnostics, Inc. for the supply and development, and possible commercialization, of Dynavax's novel Universal Influenza Vaccine in collaboration with Novartis. Under the agreement Novartis will provide Dynavax a supply of trivalent influenza vaccine, an essential component of Dynavax's Universal Influenza Vaccine, for both clinical trial use and vaccine sales. Novartis receives an exclusive option to negotiate a Joint Development and Commercialization Agreement with Dynavax.
"This agreement with one of the world's leading manufacturers and innovators in influenza vaccines...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-08-13)
More Articles from Vaccine Weekly
- Bird Flu
New bird flu study findings have been reported by scientists at Shiga University - Central Nervous System Disease
Research on central nervous system disease reported by scientists at National Institutes of Health - DNA Vaccines
Data from Harvard University provide new insights into DNA vaccines - Human Papillomavirus
Reports from N. Thones and colleagues advance knowledge in human papillomavirus - Human Papillomavirus
Studies by S.J. Liao and co-authors describe new findings in human papillomavirus - Immunization
New findings from University of Crete in the area of immunization published - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
